162 related articles for article (PubMed ID: 6957154)
1. Nutritional & pharmacologic management of hyperlipoproteinemia.
Pickering JE
Angiology; 1982 Sep; 33(9):577-80. PubMed ID: 6957154
[TBL] [Abstract][Full Text] [Related]
2. Clinical results with gemfibrozil.
Pickering JE
Am J Cardiol; 1983 Aug; 52(4):39B-40B. PubMed ID: 6351579
[No Abstract] [Full Text] [Related]
3. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
Nye ER; Sutherland WH; Temple Wa
N Z Med J; 1980 Nov; 92(671):345-9. PubMed ID: 6935550
[TBL] [Abstract][Full Text] [Related]
4. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
Kesäniemi YA; Grundy SM
JAMA; 1984 May; 251(17):2241-6. PubMed ID: 6368883
[TBL] [Abstract][Full Text] [Related]
5. Treatment of type III hyperlipoproteinemia with four different treatment regimens.
Hoogwerf BJ; Bantle JP; Kuba K; Frantz ID; Hunninghake DB
Atherosclerosis; 1984; 51(2-3):251-9. PubMed ID: 6588975
[TBL] [Abstract][Full Text] [Related]
6. Gemfibrozil in the treatment of dyslipidaemia. A 5-year follow-up study.
Manninen V; Mälkönen M; Eisalo A; Virtamo J; Tuomilehto J; Kuusisto P
Acta Med Scand Suppl; 1982; 668():82-7. PubMed ID: 6762809
[No Abstract] [Full Text] [Related]
7. Hyperlipoproteinemia, atherosclerosis and gemfibrozil.
Nash DT
Angiology; 1982 Sep; 33(9):594-602. PubMed ID: 6957155
[TBL] [Abstract][Full Text] [Related]
8. Influence of gemfibrozil on high-density lipoproteins.
Glueck C
Am J Cardiol; 1983 Aug; 52(4):31B-34B. PubMed ID: 6577782
[TBL] [Abstract][Full Text] [Related]
9. Gemfibrozil treatment and the relationship between HDL cholesterol and apoE distribution in cholesterol-fed rats.
Krause BR; Newton RS
Atherosclerosis; 1986 Sep; 61(3):245-8. PubMed ID: 3464282
[No Abstract] [Full Text] [Related]
10. A pilot study of the effect of Gemfibrozil on some haematological parameters.
O'Brien JR; Etherington MD; Shuttleworth RD; Adams CM; Middleton JE; Goodland FC
Thromb Res; 1982 May; 26(4):275-9. PubMed ID: 6955993
[TBL] [Abstract][Full Text] [Related]
11. Consensus conference: Treatment of hypertriglyceridemia.
JAMA; 1984 Mar; 251(9):1196-200. PubMed ID: 6582287
[No Abstract] [Full Text] [Related]
12. Clinical results with gemfibrozil and background to the Helsinki Heart Study.
Manninen V
Am J Cardiol; 1983 Aug; 52(4):35B-38B. PubMed ID: 6351578
[No Abstract] [Full Text] [Related]
13. Gemfibrozil--a new lipid lowering agent.
Nash DT
J Med; 1980; 11(2-3):107-16. PubMed ID: 6931871
[TBL] [Abstract][Full Text] [Related]
14. Serum lipoprotein lipids after gemfibrozil treatment.
Schwandt P; Weisweiler P; Neureuther G
Artery; 1979 Feb; 5(2):117-24. PubMed ID: 231950
[TBL] [Abstract][Full Text] [Related]
15. Long-term use of gemfibrozil (Lopid) in the treatment of dyslipidemia.
Lewis JE
Angiology; 1982 Sep; 33(9):603-12. PubMed ID: 6957156
[TBL] [Abstract][Full Text] [Related]
16. Gemfibrozil plus cholestyramine in familial hypercholesterolaemia.
Jones AF; Hughes EA; Cramb R
Lancet; 1988 Apr; 1(8588):776. PubMed ID: 2895309
[No Abstract] [Full Text] [Related]
17. Combination drug therapy for familial combined hyperlipidemia.
East C; Bilheimer DW; Grundy SM
Ann Intern Med; 1988 Jul; 109(1):25-32. PubMed ID: 3288029
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of gemfibrozil and clofibrate in type III hyperlipoproteinemia.
Larsen ML; Illingworth DR; O'Malley JP
Atherosclerosis; 1994 Apr; 106(2):235-40. PubMed ID: 8060383
[TBL] [Abstract][Full Text] [Related]
19. The hypolipidemic effect of gemfibrozil on hyperlipidemia in patients with non-insulin-dependent diabetes mellitus.
Chang DM; Fuh MM; Jeng CY; Shian LR
Taiwan Yi Xue Hui Za Zhi; 1986 May; 85(5):443-50. PubMed ID: 3463653
[No Abstract] [Full Text] [Related]
20. Studies on hypoxic dyslipidaemia. Effect of lipid modulating drugs.
Mälkönen M; Muona M; Manninen V
Acta Med Scand Suppl; 1982; 668():130-5. PubMed ID: 6963088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
